BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24801557)

  • 1. The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon.
    Aksan G; Soylu K; Aksoy O; Özdemir M; Yanik A; Yuksel S; Gedikli Ö; Gulel O; Sahin M
    Coron Artery Dis; 2014 Sep; 25(6):505-9. PubMed ID: 24801557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum YKL-40 is increased in patients with slow coronary flow.
    Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
    Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
    Sahinarslan A; Kocaman SA; Bas D; Akyel A; Ercin U; Zengin O; Timurkaynak T
    Coron Artery Dis; 2011 Aug; 22(5):333-8. PubMed ID: 21558855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
    J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography.
    Cheng JM; Akkerhuis KM; Meilhac O; Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Piquer D; Merle D; du Paty E; Galéa P; Jaisser F; Rossignol P; Serruys PW; Boersma E; Fareh J; Kardys I
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1078-84. PubMed ID: 24651681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome.
    Soylu K; Aksan G; Nar G; Özdemir M; Gülel O; İnci S; Aksakal A; Soylu Aİ; Yılmaz Ö
    Anatol J Cardiol; 2015 Jun; 15(6):450-5. PubMed ID: 25430410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
    Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction.
    Akcay AB; Ozlu MF; Sen N; Cay S; Ozturk OH; Yalcn F; Bilen P; Kanat S; Karakas MF; Isleyen A; Demir AD; Sogut S; Covic A; Kanbay M
    J Investig Med; 2012 Feb; 60(2):508-13. PubMed ID: 22222228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
    Imamaki H; Ishii A; Yokoi H; Kasahara M; Kuwabara T; Mori KP; Kato Y; Kuwahara T; Satoh M; Nakatani K; Saito Y; Tomosugi N; Sugawara A; Nakao K; Mukoyama M; Yanagita M; Mori K
    PLoS One; 2015; 10(7):e0132539. PubMed ID: 26161663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA; Williams FJ; Stivers DN; Cannon L; Dixon S; Alexander P; Runyan D; David S
    Am J Nephrol; 2012; 35(6):509-14. PubMed ID: 22627273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Salusin-β Levels Are Correlated with Slow Coronary Flow.
    Wang T; Dong AH; Cao HY
    Genet Test Mol Biomarkers; 2016 Jul; 20(7):393-7. PubMed ID: 27227272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Platelet to Lymphocyte Ratio is Related to Slow Coronary Flow.
    Akboga MK; Canpolat U; Balci KG; Akyel A; Sen F; Yayla C; Cay S; Aras D; Aydogdu S
    Angiology; 2016 Jan; 67(1):21-6. PubMed ID: 25725035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study.
    Balkanay OO; Goksedef D; Omeroglu SN; Ipek G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):209-14. PubMed ID: 25392341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase associated lipocalin as a biomarker for acute kidney injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Ninan B; Vijayalakshmi MA
    Ann Vasc Surg; 2010 May; 24(4):525-31. PubMed ID: 20363104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plateletcrit and red cell distribution width are independent predictors of the slow coronary flow phenomenon.
    Akpinar I; Sayin MR; Gursoy YC; Aktop Z; Karabag T; Kucuk E; Sen N; Aydin M; Kiran S; Buyukuysal MC; Haznedaroglu IC
    J Cardiol; 2014 Feb; 63(2):112-8. PubMed ID: 24012331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of plasma osteopontin and neutrophil gelatinase-associated lipocalin levels with the severity and clinical outcome of pelvic inflammatory disease.
    Tee YT; Wang PH; Yang SF; Tsai HT; Lee SK; Ko JL; Lin LY; Chen SC
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):158-61. PubMed ID: 25017259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.
    Shaker OG; El-Shehaby A; El-Khatib M
    Angiology; 2010 Nov; 61(8):731-6. PubMed ID: 20529972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum resistin levels in patients with coronary slow-flow phenomenon.
    Canga A; Cetin M; Kocaman SA; Durakoğlugil ME; Kırbaş A; Erdoğan T; Temiz A; Yılmaz A; Ciçek Y
    Herz; 2013 Nov; 38(7):773-8. PubMed ID: 23400345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.